No abstract available
Keywords:
biomarkers in nephrology; cardiorenal syndrome; chronic kidney disease progression; hemodialysis and cardiovascular risk; kidney transplantation.
PubMed Disclaimer
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
- Editorial on the Research Topic Kidney and heart cross-talk
References
-
-
La Porta E, Lanino L, Calatroni M, Caramella E, Avella A, Quinn C, et al. . Volume balance in chronic kidney disease: evaluation methodologies and innovation opportunities. Kidney Blood Press Res. (2021) 46:396–410. doi: 10.1159/000515172
-
DOI
-
PubMed
-
-
Mancianti N, Maresca B, Palladino M, Salerno G, Cardelli P, Menè P, et al. . Serum cardiac biomarkers in asymptomatic hemodialysis patients: role of soluble suppression of tumorigenicity-2. Blood Purif. (2022) 51:155–62. doi: 10.1159/000515675
-
DOI
-
PubMed
-
-
Deferrari G, Cipriani A, La Porta E. Renal dysfunction in cardiovascular diseases and its consequences. J Nephrol. (2021) 34:137–53. doi: 10.1007/s40620-020-00842-w
-
DOI
-
PMC
-
PubMed
-
-
Zoccali C, Mallamaci F, Halimi JM, Rossignol P, Sarafidis P, De Caterina R, et al. . From cardiorenal syndrome to chronic cardiovascular and kidney disorder: A conceptual transition. Clin J Am Soc Nephrol. (2024) 19:813–20. doi: 10.2215/CJN.0000000000000361
-
DOI
-
PMC
-
PubMed
-
-
McCullough PA, Amin A, Pantalone KM, Ronco C. Cardiorenal nexus: A review with focus on combined chronic heart and kidney failure, and insights from recent clinical trials. J Am Heart Assoc. (2022) 11:e024139. doi: 10.1161/JAHA.121.024139
-
DOI
-
PMC
-
PubMed